Focus: Forge Biologics is a public-stage biotechnology company headquartered in Grove City, OH, focused on gene therapy for rare genetic diseases. The company operates as a specialized biologics developer with early-stage pipeline programs.
Profile data last refreshed 10h ago · AI intelligence enriched 2w ago
Forge Biologics is a lean, early-stage gene therapy play best suited for scientists and manufacturing specialists willing to take on pipeline concentration risk in exchange for ground-floor involvement in a rare-disease program.
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Help build intelligence for Forge Biologics
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Generated by Claude from Forge Biologics's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Based on last 4 crawl cycles
Source: USCIS H-1B Employer Data Hub
Recent peer-reviewed publications with author affiliations at this company
Showing 5 of 10 publications
Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.
Upgrade to Pro — $25/mo